Search results for "force"

showing 10 items of 3423 documents

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.

2011

Two, once daily (q.d.) inhaled bronchodilators are available for the treatment of chronic obstructive pulmonary disease (COPD): the β(2)-agonist indacaterol and the anticholinergic tiotropium. This blinded study compared the efficacy of these two agents and assessed their safety and tolerability. Patients with moderate-to-severe COPD were randomised to treatment with indacaterol 150 μg q.d. (n=797) or tiotropium 18 μg q.d. (n=801) for 12 weeks. After 12 weeks, the two treatments had similar overall effects on "trough" (24 h post-dose) forced expiratory volume in 1 s. Indacaterol-treated patients had greater improvements in transition dyspnoea index (TDI) total score (least squares means 2.0…

Pulmonary and Respiratory MedicineSpirometryMalemedicine.drug_classScopolamine DerivativesQuinolonesSeverity of Illness IndexCholinergic AntagonistsDrug Administration ScheduleMedical Recordslaw.inventionPulmonary Disease Chronic ObstructiveRandomized controlled trialDouble-Blind MethodlawAdrenergic beta-2 Receptor AntagonistsForced Expiratory VolumemedicineAnticholinergicHumansTiotropium BromideAdverse effectAgedCOPDmedicine.diagnostic_testbusiness.industryTiotropium bromideMiddle Agedmedicine.diseaserespiratory tract diseasesBronchodilator AgentsTreatment OutcomeTolerabilitySpirometryAnesthesiaIndansIndacaterolFemalebusinessmedicine.drugThe European respiratory journal
researchProduct

Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD

2013

Expressing forced expiratory volume in 1 s (FEV1) as % predicted relies on the assumption of proportional variability and generalisability of prediction equations that may be unrealistic, especially for elderly people. We evaluated the prognostic implications of alternative ways of expressing FEV1. We enrolled 318 patients with chronic obstructive pulmonary disease (COPD) and 475 controls in the Salute Respiratoria nell'Anziano (SARA) study. The risk for 5-, 10- and 15-year mortality associated with FEV1 was studied by expressing FEV1 % pred, standardised by height cubed (FEV1 · Ht(-3)) and as a multiple of the sex-specific first percentile (FEV1 quotient (FEV1Q)). In the group with COPD, t…

Pulmonary and Respiratory MedicineSpirometryMalemedicine.medical_specialtyPediatricsPercentilePrognosiPulmonary diseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioRate ratioPulmonary Disease Chronic ObstructiveElderly populationInternal medicineForced Expiratory VolumeHumansMedicineElderly peopleRespiratory Function TestAgedCOPDmedicine.diagnostic_testbusiness.industryRespiratory Function Tests; Spirometry; Humans; Treatment Outcome; Prognosis; Case-Control Studies; Aged; Middle Aged; Forced Expiratory Volume; Male; Female; Pulmonary Disease Chronic ObstructiveCase-control studyrespiratory systemMiddle AgedPrognosismedicine.diseaseRespiratory Function Testsrespiratory tract diseasesTreatment OutcomeSpirometryCase-Control StudiesFemalebusinessCase-Control StudieHuman
researchProduct

Small airways function and molecular markers in exhaled air in mild asthma.

2005

Background: Several studies suggest that the periphery of the lung is the major site of inflammation in asthma. Fractional exhaled nitric oxide (FeNO) and 8-isoprostane have been proposed as biomarkers of inflammation and oxidative stress. We therefore hypothesised that small airway dysfunction in asthma is of inflammatory origin that can be detected by molecular markers in exhaled air. To test this hypothesis, we examined the relationship of FeNO and 8-isoprostane in exhaled air with small airways function as assessed by the single breath nitrogen test. Methods: Sixteen patients (14 women) with mild atopic asthma (forced expiratory volume in 1 second >80% predicted) of mean (SD) age 23.0 (…

Pulmonary and Respiratory MedicineSpirometrySmall airwayAdultMalemedicine.medical_specialtyVital CapacityEnzyme-Linked Immunosorbent AssaySettore MED/10 - Malattie Dell'Apparato RespiratorioDinoprostNitric OxideGastroenterologyNitric oxidechemistry.chemical_compoundInternal medicineForced Expiratory VolumemedicineHumansExhaled breath condensateBronchitisAsthmaLungmedicine.diagnostic_testbusiness.industryRespiratory diseaserespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesmedicine.anatomical_structureCross-Sectional StudieschemistryExhaled nitric oxideImmunologyBronchitisFemalebusinessBiomarkersThorax
researchProduct

Validation of FEV6 in the elderly: correlates of performance and repeatability.

2007

BACKGROUND: Forced expiratory volume in 6 s (FEV6) has been proposed as a more easily measurable parameter than forced vital capacity (FVC) to diagnose airway disease using spirometry. A study was undertaken to estimate FEV6 repeatability, to identify correlates of a good quality FEV6 measurement and of volumetric differences between FEV6 and FVC in elderly patients. METHODS: 1531 subjects aged 65-100 years enrolled in the SA.R.A project (a cross-sectional multicentre non-interventional study) were examined. FEV6 was measured on volume-time curves that achieved satisfactory start-of-test and end-of-test criteria. Correlates of FEV6 achievement were assessed by logistic regression. RESULTS: …

Pulmonary and Respiratory MedicineSpirometryVital capacitymedicine.medical_specialtyCross-sectional studyPopulationVital CapacitySettore MED/10 - Malattie Dell'Apparato RespiratorioLogistic regressionFEV1/FVC ratioForced Expiratory VolumemedicineHumanseducationAgedAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryReproducibility of ResultsBronchial DiseasesRepeatabilityrespiratory systemAirway obstructionlung function agingmedicine.diseaserespiratory tract diseasesCross-Sectional StudiesPhysical therapybusiness
researchProduct

Early childhood growth is associated with lung function at 7 years: a prospective population-based study

2020

Previous studies have related early postnatal growth with later lung function but their interpretation is limited by the methods used to assess a child's growth. We aimed to assess the association of early childhood growth, measured by body mass index (BMI) trajectories up to 4 years, with lung function at 7 years.We included 1257 children from the Spanish Infancia y Medio Ambiente population-based birth cohort. Early childhood growth was classified into five categories based on BMI trajectories up to 4 years previously identified using latent class growth analysis. These trajectories differed in birth size ("lower", "average", "higher") and in BMI gain velocity ("slower", "accelerated"). W…

Pulmonary and Respiratory MedicineVital capacityVital CapacityPopulation03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineForced Expiratory VolumeHumansMedicineProspective Studies030212 general & internal medicineEarly childhoodPostnatal growthChildeducationLungLung function2. Zero hungereducation.field_of_studybusiness.industryrespiratory systemRespiratory Function TestsPopulation based study030228 respiratory systemChild PreschoolPulmonsbusinessBody mass indexDemographyInfància
researchProduct

A simple noninvasive pressure–time index at the mouth to measure respiratory load during acute exacerbation of COPD A comparison with normal voluntee…

2003

We assessed the validity of the pressure-time index (PTI) measured at the mouth as a noninvasive and simplified alternative to conventional tension-time index for assessing respiratory load and inspiratory muscle force reserve. PTI was measured within 48 h of hospital admission and at 24 h before discharge in 37 consecutive patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) using the equation PTI = (P(awo)/MIP)(T(I)/T(T)) 100, where P(awo) is the mean airway pressure measured at the mouth, MIP the maximal inspiratory pressure, and T(I)/T(T) the inspiratory time (T(I)) to total cycle length (T(T)) ratio. Controls were 30 normal volunteers with similar anthropome…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAcute exacerbation of chronic obstructive pulmonary diseaseTime FactorsExacerbationPartial PressureVital CapacityPopulationMean airway pressurechronic obstructive pulmonary diseasePulmonary Disease Chronic ObstructiveForced Expiratory VolumeInternal medicinePressureRespiratory musclemedicineHumansRespiratory systemeducationAgedWork of Breathingeducation.field_of_studyCOPDbusiness.industryRespirationRespiratory diseaseCarbon Dioxidemedicine.diseaseRespiratory MusclesSurgeryOxygenrespiratory muscle fatiguerespiratory loadCardiologyFeasibility StudiesBlood Gas Analysispressure–time indexbusinessRespiratory Medicine
researchProduct

Severe eosinophilic asthma: a roadmap to consensus

2017

Asthma is widely accepted as a complex heterogeneous condition with diverse pathophysiological mechanisms, clinical presentations, comorbidities, physiological characteristics, pathology and outcomes that is typically best managed by a multidisciplinary team [1–4]. Severe asthma is recognised as a major unmet need with a high personal and social impact, as well as a high burden on healthcare resources [4]. As a consequence of advances in the development of precision medicines for patients with severe asthma, the need to identify asthma subtypes by phenotype based on clinical, functional or inflammatory parameters is becoming a mandatory part of management [4–6]. Severe eosinophilic asthma (…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyConsensusEosinophilic asthmamacromolecular substancesSeverity of Illness IndexBiological Factors03 medical and health sciences0302 clinical medicineimmune system diseasesEosinophilicmedicineHumans030212 general & internal medicinePulmonary EosinophiliaIntensive care medicineSocieties MedicalTask forcebusiness.industryDisease ManagementAsthmarespiratory tract diseasesEurope030228 respiratory systemImmunologybusinessEuropean Respiratory Journal
researchProduct

The Association Between Bone Mineral Density and Airflow Limitation in a Cohort of Fit Elderly Women

2016

Purpose: As studies examining the association between bone mineral density (BMD) and airflow limitation (AL) have produced conflicting results, the current one set out to analyze if and to what degree there are any correlations between these variables in a population of fit elderly women. Methods: One hundred and twenty-one non-smoking, fit and healthy women (age ≥ 65 years) underwent anthropometric assessment, laboratory testing (serum 25-hydroxy vitamin D, parathormone, and cytokine levels), pulmonary function testing (PFT), and dual-energy X-ray absorptiometry to evaluate BMD values of the lumbar and femoral regions. Results: A significant positive association was found between FEV1/FVC …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyVital CapacityPopulation030209 endocrinology & metabolismNO03 medical and health sciencesFEV1/FVC ratioAbsorptiometry Photon0302 clinical medicineLumbarElderlyAirflow limitationBone DensityForced Expiratory VolumeInternal medicinemedicineBone mineral densityHumanseducationAgedFemoral neckBone mineraleducation.field_of_studyLumbar VertebraeTrochanterAirflow limitation; Bone mineral density; Elderly; Pulmonary function testFemur Neckbusiness.industryPulmonary function testPulmonary function test Airflow limitation Bone mineral density ElderlyAnthropometryHealthy VolunteersSurgerymedicine.anatomical_structure030228 respiratory systemQuartilePhysical FitnessFemalebusiness
researchProduct

Assessing and accessing the small airways; implications for asthma management

2013

Despite the wealth of experience in the management of asthma, the disease remains inadequately controlled in some patients, who face long-term respiratory impairment and disability. The disease has been characterised as an inflammatory condition affecting first the larger airways and eventually the smaller airways, but there is evidence that peripheral airway involvement defines a particular and more severe phenotype of asthma. For this reason, assessing functional and biological parameters reflective of small airways involvement is important prognostically. No assessment method is universally and directly representative of peripheral airway function, but the traditional spirometric tests, …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyVital capacityVital CapacityDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioAsthma managementAir trappingNitric OxideNitric Oxide; Respiratory Function Tests; Vital Capacity; Humans; Tomography X-Ray Computed; Asthma; Forced Expiratory Volume; Breath TestsForced Expiratory VolumeMedicineHumansPharmacology (medical)Intensive care medicineAsthmaRespiratory Function Testbusiness.industrySmall airwaysBiochemistry (medical)medicine.diseaseResponse to treatmentAsthmarespiratory tract diseasesRespiratory Function TestsImpulse OscillometryBreath TestsAnesthesiamedicine.symptombusinessTomography X-Ray ComputedHuman
researchProduct

Should we use gait speed in COPD, FEV 1 in frailty and dyspnoea in both?

2016

Frailty is a progressive physiological decline in multiple organ systems marked by loss of function, loss of physiological reserve and increased vulnerability to disease [1]. Biological (inflammation and loss of hormones), clinical ( e.g. sarcopenia and osteoporosis) and social factors are involved in frailty onset, evolution and prognosis [2, 3]. Links between frailty, dyspnoea and chronic respiratory diseases represent a novel and practical approach

Pulmonary and Respiratory Medicinemedicine.medical_specialty[SDV]Life Sciences [q-bio]OsteoporosisDiseaseIdoso FragilizadoDispneia03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicineForced Expiratory VolumemedicineHumans030212 general & internal medicineLoss functionOrgan systemComputingMilieux_MISCELLANEOUSAgedAged 80 and overCOPDFrailtybusiness.industrymedicine.disease3. Good healthGait speedWalking SpeedPreferred walking speedDyspnea030228 respiratory systemSarcopeniaPhysical therapyCardiologyDoença Pulmonar Obstrutiva CrónicaVolume Expiratório ForçadoAged; Aged 80 and over; Dyspnea; Forced Expiratory Volume; Frailty; Humans; Pulmonary Disease Chronic Obstructive; Walking Speed; Pulmonary and Respiratory MedicinebusinessHuman
researchProduct